Literature DB >> 12210153

Binding of D- and L-captopril inhibitors to metallo-beta-lactamase studied by polarizable molecular mechanics and quantum mechanics.

Jens Antony1, Nohad Gresh, Lars Olsen, Lars Hemmingsen, Christopher J Schofield, Rogert Bauer.   

Abstract

The bacterial Zn2+ metallo-beta-lactamase from B. fragilis is a zinc-enzyme with two potential metal ion binding sites. It cleaves the lactam ring of antibiotics, thus contributing to the acquired resistance of bacteria against antibiotics. The present study bears on the binuclear form of the enzyme. We compare several possible binding modes of captopril, a mercaptocarboxamide inhibitor of several zinc-metalloenzymes. Two diastereoisomers of captopril were considered, with either a D- or an L-proline residue. We have used the polarizable molecular mechanics procedure SIBFA (Sum of Interactions Between Fragments ab initio computed). Two beta-lactamase models were considered, encompassing 104 and 188 residues, respectively. The energy balances included the inter and intramolecular interaction energies as well as the contribution from solvation computed using a continuum reaction field procedure. The thiolate ion of the inhibitor is binding to both metal ions, expelling the bridging solvent molecule from the uncomplexed enzyme. Different competing binding modes of captopril were considered, either where the inhibitor binds in a monodentate mode to the zinc cations only with its thiolate ion, or in bidentate modes involving additional zinc binding by its carboxylate or ketone carbonyl groups. The additional coordination by the inhibitor's carboxylate or carbonyl group always occurs at the zinc ion, which is bound by a histidine, a cysteine, and an aspartate side chain. For both diastereomers, the energy balances favor monodentate binding of captopril via S-. The preference over bidentate binding is small. The interaction energies were recomputed in model sites restricted to captopril, the Zn2+ cations, and their coordinating end side chains from beta-lactamase (98 atoms). The interaction energies and their ranking among competing arrangements were consistent with those computed by ab initio HF and DFT procedures. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12210153     DOI: 10.1002/jcc.10111

Source DB:  PubMed          Journal:  J Comput Chem        ISSN: 0192-8651            Impact factor:   3.376


  12 in total

1.  Impact of remote mutations on metallo-beta-lactamase substrate specificity: implications for the evolution of antibiotic resistance.

Authors:  Peter Oelschlaeger; Stephen L Mayo; Juergen Pleiss
Journal:  Protein Sci       Date:  2005-03       Impact factor: 6.725

2.  A structural view of the antibiotic degradation enzyme NDM-1 from a superbug.

Authors:  Yu Guo; Jing Wang; Guojun Niu; Wenqing Shui; Yuna Sun; Honggang Zhou; Yaozhou Zhang; Cheng Yang; Zhiyong Lou; Zihe Rao
Journal:  Protein Cell       Date:  2011-06-02       Impact factor: 14.870

Review 3.  Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.

Authors:  Carine Bebrone; Patricia Lassaux; Lionel Vercheval; Jean-Sébastien Sohier; Adrien Jehaes; Eric Sauvage; Moreno Galleni
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

4.  Bulgecin A: a novel inhibitor of binuclear metallo-beta-lactamases.

Authors:  Alan M Simm; E Joel Loveridge; John Crosby; Matthew B Avison; Timothy R Walsh; Peter M Bennett
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

5.  Modeling Structural Coordination and Ligand Binding in Zinc Proteins with a Polarizable Potential.

Authors:  Jiajing Zhang; Wei Yang; Jean-Philip Piquemal; Pengyu Ren
Journal:  J Chem Theory Comput       Date:  2012-01-02       Impact factor: 6.006

6.  Anisotropic, Polarizable Molecular Mechanics Studies of Inter- and Intramolecular Interactions and Ligand-Macromolecule Complexes. A Bottom-Up Strategy.

Authors:  Nohad Gresh; G Andrés Cisneros; Thomas A Darden; Jean-Philip Piquemal
Journal:  J Chem Theory Comput       Date:  2007-11       Impact factor: 6.006

7.  Structure-Based Virtual Screening for the Discovery of Novel Inhibitors of New Delhi Metallo-β-lactamase-1.

Authors:  Francesca Spyrakis; Giuseppe Celenza; Francesca Marcoccia; Matteo Santucci; Simon Cross; Pierangelo Bellio; Laura Cendron; Mariagrazia Perilli; Donatella Tondi
Journal:  ACS Med Chem Lett       Date:  2017-11-26       Impact factor: 4.345

8.  Molecular docking studies, in-silico ADMET predictions and synthesis of novel PEGA-nucleosides as antimicrobial agents targeting class B1 metallo-β-lactamases.

Authors:  Jesica A Mendoza; Richard Y Pineda; Michelle Nguyen; Marisol Tellez; Ahmed M Awad
Journal:  In Silico Pharmacol       Date:  2021-04-16

9.  Monitoring conformational changes in the NDM-1 metallo-β-lactamase by 19F NMR spectroscopy.

Authors:  Anna M Rydzik; Jürgen Brem; Sander S van Berkel; Inga Pfeffer; Anne Makena; Timothy D W Claridge; Christopher J Schofield
Journal:  Angew Chem Int Ed Engl       Date:  2014-02-24       Impact factor: 15.336

10.  Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers.

Authors:  Jürgen Brem; Sander S van Berkel; David Zollman; Sook Y Lee; Opher Gileadi; Peter J McHugh; Timothy R Walsh; Michael A McDonough; Christopher J Schofield
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.